1.38
price down icon1.43%   -0.02
after-market 시간 외 거래: 1.39 0.01 +0.72%
loading
전일 마감가:
$1.40
열려 있는:
$1.39
하루 거래량:
197.67K
Relative Volume:
0.29
시가총액:
$63.08M
수익:
-
순이익/손실:
$-40.56M
주가수익비율:
-1.1795
EPS:
-1.17
순현금흐름:
$-35.28M
1주 성능:
-12.66%
1개월 성능:
+9.52%
6개월 성능:
-36.99%
1년 성능:
-53.22%
1일 변동 폭
Value
$1.33
$1.4251
1주일 범위
Value
$1.33
$1.575
52주 변동 폭
Value
$0.8505
$4.42

Pds Biotechnology Corporation Stock (PDSB) Company Profile

Name
명칭
Pds Biotechnology Corporation
Name
전화
800-208-3343
Name
주소
303A COLLEGE ROAD EAST, PRINCETON
Name
직원
24
Name
트위터
@pdsbiotech
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
PDSB's Discussions on Twitter

PDSB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PDSB
Pds Biotechnology Corporation
1.38 72.22M 0 -40.56M -35.28M -1.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-01 개시 B. Riley Securities Buy
2021-06-28 개시 Cantor Fitzgerald Overweight
2020-11-10 업그레이드 H.C. Wainwright Neutral → Buy
2020-05-27 개시 Alliance Global Partners Buy
2020-03-09 개시 Noble Capital Markets Outperform
2019-10-24 개시 Chardan Capital Markets Buy
모두보기

Pds Biotechnology Corporation 주식(PDSB)의 최신 뉴스

pulisher
May 28, 2025

PDS Biotechnology files to sell 9.82M shares of common stock for holders - MSN

May 28, 2025
pulisher
May 28, 2025

PDS Biotechnology (PDSB) Announces Plan to Offer 9.82 Million Sh - GuruFocus

May 28, 2025
pulisher
May 27, 2025

PDS Biotechnology (PDSB) Plans Sale of 9.82 Million Shares | PDS - GuruFocus

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades PDS Biotechnology (NASDAQ:PDSB) to “Hold” - Defense World

May 24, 2025
pulisher
May 23, 2025

PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial - Insider Monkey

May 23, 2025
pulisher
May 23, 2025

Transcript : PDS Biotechnology CorporationSpecial Call - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Q2 EPS Estimates for PDS Biotechnology Raised by B. Riley - Defense World

May 23, 2025
pulisher
May 23, 2025

PDS Biotech reports extended survival in HPV cancer study - Investing.com Australia

May 23, 2025
pulisher
May 22, 2025

PDS Biotech reports extended survival in HPV cancer study By Investing.com - Investing.com India

May 22, 2025
pulisher
May 22, 2025

PDS Biotechnology Reports Promising Overall Survival Data for Versamune® HPV Combined with Pembrolizumab in HPV16-Positive Head and Neck Cancer - Nasdaq

May 22, 2025
pulisher
May 22, 2025

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - TradingView

May 22, 2025
pulisher
May 22, 2025

PDS Biotech at A.G.P. Showcase: Versamune’s Promising Potential By Investing.com - Investing.com South Africa

May 22, 2025
pulisher
May 21, 2025

PDS Biotech at A.G.P. Showcase: Versamune’s Promising Potential - Investing.com

May 21, 2025
pulisher
May 20, 2025

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase - The Manila Times

May 20, 2025
pulisher
May 17, 2025

PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript - MSN

May 17, 2025
pulisher
May 16, 2025

PDS Biotech outlines continued VERSATILE 003 Phase 3 expansion while advancing HPV16-positive head and neck cancer strategy - MSN

May 16, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes $26,000 Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 15, 2025
pulisher
May 15, 2025

PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

PDS Biotechnology Reports Q1 2025 Progress and Financials - TipRanks

May 15, 2025
pulisher
May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

PDS Biotechnology: Q1 Earnings Snapshot - Midland Daily News

May 14, 2025
pulisher
May 14, 2025

EMV Capital portfolio company PDS Biotech advances cancer trial - Proactive Investors

May 14, 2025
pulisher
May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: PDS Biotech’s Q1 2025 results show reduced losses - Investing.com

May 14, 2025
pulisher
May 14, 2025

Transcript : PDS Biotechnology Corporation, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

PDSB Advances with Phase 3 Trial for Versamune HPV Therapy | PDS - GuruFocus

May 14, 2025
pulisher
May 14, 2025

PDS Biotechnology Corporation Initiates VERSATILE-003 Phase 3 Trial and Announces Abstracts Selected for ASCO 2025 - Nasdaq

May 14, 2025
pulisher
May 14, 2025

PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update - TradingView

May 14, 2025
pulisher
May 13, 2025

PDS Biotechnology (PDSB) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 09, 2025

Pds Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 09, 2025
pulisher
May 08, 2025

PDS Biotechnology Unveils Promising Flu Vaccine Data - TipRanks

May 08, 2025
pulisher
May 08, 2025

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting - The Manila Times

May 08, 2025
pulisher
May 07, 2025

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results - TradingView

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Has $64,000 Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 07, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Acquires 76,800 Shares of PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 07, 2025
pulisher
May 06, 2025

THE CANADIAN INTERNATIONAL TRADE TRIBUNAL TERMINATES ITS PRELIMINARY INJURY INQUIRY IN RESPECT OF TIDEWATER RENEWABLES LTD.'S COUNTERVAILING (ANTI-SUBSIDY) AND ANTI-DUMPING DUTY COMPLAINT RELATING TO I - The Globe and Mail

May 06, 2025
pulisher
May 04, 2025

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript - MSN

May 04, 2025
pulisher
May 02, 2025

PDS Biotechnology Enters $20M Securities Purchase Agreement - TipRanks

May 02, 2025
pulisher
Apr 25, 2025

B. Riley Adjusts Price Target on PDS Biotechnology to $5 From $7, Maintains Buy Rating - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

B. Riley Expects Stronger Earnings for PDS Biotechnology - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

PDS Biotechnology Director Sir Richard Sykes Retires - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

PDS Biotechnology Corporation Announces Three Abstracts Accepted for ASCO 2025 on Versamune® HPV Immunotherapy - Nasdaq

Apr 23, 2025
pulisher
Apr 16, 2025

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting - The Manila Times

Apr 16, 2025
pulisher
Apr 14, 2025

Raymond James Financial Inc. Takes Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Apr 14, 2025
pulisher
Apr 08, 2025

Pds Biotech Announces Pds01adc Clinical Data To Be Presented At The American Association For Cancer Research - MarketScreener

Apr 08, 2025

Pds Biotechnology Corporation (PDSB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):